Skip to search formSkip to main contentSkip to account menu

pivalyloxymethyl butyrate

Known as: Pivaloyloxymethyl butyrate, Pivaloyloxymethylbutyrate 
An acyloxyalkyl ester prodrug of butyric acid. Pivaloyloxymethylbutyrate inhibits histone deacetylase, resulting in cell differentiation, cell growth… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Anthracyclines are frequently used to treat many cancers including triple negative breast cancer, which is commonly observed in… 
2007
2007
The anthracycline group of compounds is extensively used in current cancer chemotherapy regimens and is classified as… 
2005
2005
A novel butyric acid derivative, pivaloyloxymethyl butyrate, AN-9, was previously shown to be a potent differentiating agent. AN… 
2004
2004
The anti-proliferative effects of pivaloyloxymethyl butyrate (AN-9), a butyric acid (BA) derivative with potent tumor… 
2004
2004
The ability of mitoxantrone to form DNA adducts was investigated in a series of human tumor cell lines consisting of human… 
2003
2003
In addition to its action as a topoisomerase II poison, mitoxantrone is activated by formaldehyde to bind DNA, forming DNA… 
2001
2001
The interaction of Adriamycin and pivaloyloxymethyl butyrate (AN-9) was investigated in IMR-32 neuroblastoma and MCF-7 breast… 
2000
2000
Abstract Pivaloyloxymethyl butyrate (AN-9), a butyric acid (BA) prodrug, exhibited low toxicity and significant anticancer… 
1996
1996
Pivaloyloxymethyl butyrate (AN-9) belongs to the family of acyloxyalkyl ester prodrugs of carboxylic acids which undergo… 
1994
1994
A study of the effects of three differentiating agents, butyric acid, retinoic acid and cytosine arabinoside on proliferation and…